R&D+i strategy
Our research uncovers the full potential of innovation and quality in our products, strengthening our presence in key therapeutic areas and enabling new commercial agreements to create synergies with global pharmaceutical companies.
We focus our research efforts on developing and innovating new medicines that can offer clinical benefits for people in therapeutic areas where we aspire to gain a leading position.
+ 90 years
+ 100 employees
+ 4,000 m2
11 products
2,494 patients
The three pillars of R&D+i:
1. Biology and medicinal chemistry.
Our goal is to identify and validate target groups in our therapeutic areas by developing bioassays and characterising and assessing the activities of our drug candidates.
For this, we have molecular and cellular biology laboratories, as well as a team and facilities for the development of in vivo models of various diseases of interest.
Our general objective in this field is the rational design and development of new and effective chemical entities, supported by bioassays.
A wide range of data analysis and synthetic chemistry techniques are used to facilitate the design of pharmaceutically active molecules to treat a specific disease.
This area is also involved in developing new and improved manufacturing processes to produce medicines at a Kilo Lab scale effectively, economically and in an environmentally friendly way.
2. Pharmaceutical development.
Introducing new pharmaceutical technologies and particle engineering is also a fundamental aspect of our work. Partnerships with academic and private institutions allows us to broaden our knowledge beyond the spectrum that exists in-house.
3. Clinical research.
Clinical development of new medicines involves conducting Clinical Trials to test their efficacy and safety.
At Faes Farma, we conduct various types of clinical trials simultaneously, adhering to the most stringent quality standards and following European Regulations and Guidelines, Good Clinical Practices, and FDA (U.S. Food and Drug Administration Good Clinical Practice) regulations, as well as meeting specific requirements of authorities in participating countries.
A clinical trial is a research study through which we evaluate the safety and efficacy of a treatment. We answer all frequently asked questions about clinical trials.
ENSAYOS CLINICOS EN
